Skip to main
CRDL

Cardiol Therapeutics (CRDL) Market Capitalization Overview

Market Cap: $99.73M as of Jan 9, 2026

$99.73M
$8.27M (7.66%)past month
As of Jan 9, 2026, Cardiol Therapeutics (CRDL) has a market capitalization of $99.73M. Over the past 30 days, its market cap has increased by 4.65%, while in the last 12 months, it has increased by 4.56%.

Market capitalization represents the total value of Cardiol Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Cardiol Therapeutics (CRDL) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Cardiol Therapeutics (CRDL) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Cardiol Therapeutics (CRDL) Market Cap History

DateMarket CapChange
Dec 1, 2025$94.99M+3.61%
Nov 3, 2025$91.69M+2.34%
Oct 1, 2025$89.60M-1.46%
Sep 2, 2025$90.92M-20.29%
Aug 1, 2025$114.06M+4.55%
Jul 1, 2025$109.10M+6.45%
Jun 2, 2025$102.49M+10.74%
May 1, 2025$92.55M+22.26%
Apr 1, 2025$75.70M-14.90%
Mar 3, 2025$88.95M-18.05%
Feb 3, 2025$108.54M-2.92%
Jan 2, 2025$111.80M-12.74%

Cardiol Therapeutics (CRDL) End of Year Market Cap History

DateMarket CapChange
2026$99.73M+4.56%
2025$95.38M-8.69%
2024$104.46M+90.25%
2023$54.91M+71.75%
2022$31.97M-33.24%
2021$47.89M

FAQs About Cardiol Therapeutics (CRDL) Market Cap

As of Jan 9, 2026, the market capitalization of Cardiol Therapeutics (CRDL) is $99.73M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Cardiol Therapeutics’s market capitalization has decreased by -7.66%, changing from $107.99M to $99.73M as of Jan 9, 2026.

In the last 3 months, Cardiol Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Cardiol Therapeutics’s market capitalization decreased from $104.46M in January to $95.38M in December, reflecting a -8.69% change.

In the past five years, Cardiol Therapeutics (CRDL) has had a compound annual growth rate (CAGR) of 14.77% in market capitalization. This means its market cap has grown at an average rate of 14.77% per year.

Cardiol Therapeutics (CRDL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.